ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08552
-0,05%
Bitcoin
71.289,86
-0,22%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. InMed Pharmaceuticals Inc (INM)

  7. InMed Pharmaceuticals Inc (INM) News

INM

InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INM
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202421h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202421h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202421h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
27/02/202421h27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
22/02/202419h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
21/02/202420h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
13/02/202423h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMInMed Pharmaceuticals Inc
09/02/202418h34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
19/01/202420h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
16/01/202420h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
26/12/202319h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
21/12/202323h21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INMInMed Pharmaceuticals Inc
06/12/202315h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
29/11/202320h50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
14/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMInMed Pharmaceuticals Inc
13/11/202323h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INMInMed Pharmaceuticals Inc
08/11/202323h05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INMInMed Pharmaceuticals Inc
02/11/202319h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322h04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
24/10/202322h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INM

Kürzlich von Ihnen besucht

NYSE
NKE
Nike
USOTC
RHHBY
Roche (QX)
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BASFY
BASF (QX)
AMEX
XLE
Energy Select Sector SPDR
TG
DTE
Deutsche Telekom
AMEX
SPY
SPDR S&P 500
USOTC
BNPQY
BNP Paribas (QX)
TG
CBK
Commerzbank
NYSE
JPM
JP Morgan Chase
DBI
MDAX
MDAX
FX
EURGBP
Euro vs Sterling
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten